Skip to main content
. 2022 May 25;10:e13296. doi: 10.7717/peerj.13296

Table 4. Difference in perception regarding telepharmacy implantation by sample characteristics.

Variables Perception regarding telepharmacy benefits Perception regarding eligibility Perception regarding regulatory issues Perception regarding telepharmacy in COVID-19 pandemic and beyond
Negative Positive χ2 p Negative Positive χ2 p Negative Positive χ2 p Negative Positive χ2 p
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Gender 0.98 0.321 3.12 0.07 4.56 0.03 2.90 0.08
Female 29 (20.4) 113 (79.6) 93 (65.5) 49 (34.5) 55 (38.7) 87 (61.3) 48 (33.8) 94 (66.2)
Male 39 (16.4) 199 (83.6) 134 (56.3) 104 (43.7) 67 (28.2) 171 (71.8) 61 (25.6) 177 (74.4)
Age 1.06 0.59 4.74 0.09 6.18 0.03 6.90 0.03
20–29 years 54 (19.1) 229 (80.9) 178 (62.9) 105 (37.1) 100 (35.3) 183 (64.7) 91 (32.2) 192 (67.8)
30–39 years 13 (14.4) 77 (85.6) 45 (50.0) 45 (50.0) 19 (21.1) 71 (78.9) 169 (17.8) 74 (82.2)
40 years & above 1 (14.3) 6 (85.7) 4 (57.1) 3 (42.9) 3 (42.9) 4 (57.1) 2 (28.6) 5 (71.4)
Job location 0.94 0.62 6.02 0.04 1.08 0.58 1.83 0.41
Community Pharmacy 25 (20.7) 96 (79.3) 66 (54.5) 55 (45.5) 35 (28.9) 86 (71.1) 39 (32.2) 82 (67.8)
Hospital Pharmacy 13 (16.0) 68 (84.0) 43 (53.1) 38 (46.9) 29 (35.8) 52 (64.2) 19 (23.5) 62 (76.5)
Others 30 (16.9) 148 (83.1) 118 (66.3) 60 (33.7) 58 (32.6) 120 (67.4) 51 (28.7) 127 (71.3)
Province 4.72 0.31 4.19 0.38 1.19 0.88 4.14 0.39
Baluchistan 9 (18.8) 39 (81.2) 25 (52.1) 23 (47.9) 16 (33.3) 32 (66.7) 12 (25.0) 36 (75.0)
GB 5 (26.3) 14 (73.7) 14 (73.7) 5 (26.3) 5 (26.3) 14 (73.7) 6 (31.6) 13 (68.4)
KPK 17 (12.6) 118 (87.4) 76 (56.3) 59 (43.7) 40 (29.6) 95 (70.4) 32 (23.7) 103 (76.3)
Punjab 22 (19.8) 89 (80.2) 69 (62.2) 42 (37.8) 39 (35.1) 72 (64.9) 35 (31.5) 76 (68.5)
Sindh 15 (22.4) 52 (77.6) 43 (64.2) 24 (35.8) 22 (32.8) 45 (67.2) 24 (35.8) 43 (64.2)

Note:

Bold represent significant results with p-value <0.05.